Get startedLog in
    Picture of Optipharm Co logo

    153710 — Optipharm Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareBalancedMicro CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Optipharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-2,352-3,080-2,045-2,437-2,357
    Depreciation
    Amortisation
    Non-Cash Items-679-1,181-1,32665.6848
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital4301,215-184-785-701
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-1,617-1,969-2,434-1,723-595
    Capital Expenditures-955-757-4,604-1,737-1,736
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-3,002-6,6302,665-1,8522,756
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-3,956-7,387-1,939-3,5891,020
    Financing Cash Flow Items-135-156-130-147-197
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities1,1061,8191,7601,993943
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-4,467-7,538-2,613-3,3191,367